GB1375544A - - Google Patents

Info

Publication number
GB1375544A
GB1375544A GB4026070A GB4026070A GB1375544A GB 1375544 A GB1375544 A GB 1375544A GB 4026070 A GB4026070 A GB 4026070A GB 4026070 A GB4026070 A GB 4026070A GB 1375544 A GB1375544 A GB 1375544A
Authority
GB
United Kingdom
Prior art keywords
organisms
vaccine
nodosus
killing
contain
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
GB4026070A
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed filed Critical
Priority to GB4026070A priority Critical patent/GB1375544A/en
Priority to US00172309A priority patent/US3843451A/en
Priority to IT52380/71A priority patent/IT1045527B/en
Priority to FR7130222A priority patent/FR2103402B1/fr
Priority to AU32522/71A priority patent/AU451635B2/en
Priority to BE771536A priority patent/BE771536A/en
Priority to JP6330571A priority patent/JPS5545192B1/ja
Priority to IE1051/71A priority patent/IE35729B1/en
Priority to ZA715544A priority patent/ZA715544B/en
Priority to NO3094/71A priority patent/NO141564C/en
Priority to NL7111442A priority patent/NL7111442A/xx
Priority to DE2141901A priority patent/DE2141901C3/en
Priority to DE2167168A priority patent/DE2167168C2/en
Priority to NO2548/72A priority patent/NO141565C/en
Priority to AR19595473D priority patent/AR195954A1/en
Publication of GB1375544A publication Critical patent/GB1375544A/en
Expired legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/02—Bacterial antigens
    • A61K39/114—Fusobacterium
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N1/00—Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
    • C12N1/20—Bacteria; Culture media therefor
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P33/00—Preparation of steroids

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • Biotechnology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Microbiology (AREA)
  • Medicinal Chemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • Virology (AREA)
  • Biomedical Technology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Immunology (AREA)
  • Mycology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)

Abstract

1375544 Fusiformis nodosus vaccine WELLCOME FOUNDATION Ltd 19 Nov 1971 [20 Aug 1970 19 Aug 1971] 40260/70 and 39083/71 Heading A5B [Also in Division C6] A Fusiformis nodosus vaccine is prepared by cultivating F. nodosus anaerobically in a liquid nutrient medium containing in solution, crude trypsin or a digest of pancreas, and a liver digest, extract or infusion, killing the organisms and incorporating them in a container as a sterile vaccine preparation. The organisms may be separated from the culture prior to killing, which killing may be performed with formalin. The killed organisms may be incorporated in the aqueous phase of a water in oil emulsion, which emulsion may contain non-ionic hydrophilic and lipophilic emulsifiers. The vaccine may alternatively contain an aluminium adjuvant. It preferably contains 2.5 x 10<SP>7</SP>-2.5 x 10<SP>9</SP> killed organisms/ml of preparation and may contain one or more immunogenic antigens derived from other organisms e.g. clostridial organisms or F. necrophorus.
GB4026070A 1970-08-20 1970-08-20 Expired GB1375544A (en)

Priority Applications (15)

Application Number Priority Date Filing Date Title
GB4026070A GB1375544A (en) 1970-08-20 1970-08-20
US00172309A US3843451A (en) 1970-08-20 1971-08-16 Microorganism production
IT52380/71A IT1045527B (en) 1970-08-20 1971-08-19 METHOD TO PRODUCE A VACCINE FOR THE PREVENTION AND TREATMENT OF THE ULCER OF THE LEGS OF THE VINES AND RELATED PRODUCT
FR7130222A FR2103402B1 (en) 1970-08-20 1971-08-19
AU32522/71A AU451635B2 (en) 1970-08-20 1971-08-19 Vaccine preparation
BE771536A BE771536A (en) 1970-08-20 1971-08-19 PREPARING A VACCINE
JP6330571A JPS5545192B1 (en) 1970-08-20 1971-08-19
IE1051/71A IE35729B1 (en) 1970-08-20 1971-08-19 Vaccine preparation
ZA715544A ZA715544B (en) 1970-08-20 1971-08-19 Vaccine preparation
NO3094/71A NO141564C (en) 1970-08-20 1971-08-19 PROCEDURE FOR CULTIVATING FUSIFORMIS NODOSUS
NL7111442A NL7111442A (en) 1970-08-20 1971-08-19
DE2141901A DE2141901C3 (en) 1970-08-20 1971-08-20 Sterile vaccine containing killed organisms of the genus Fusiformis nodosus
DE2167168A DE2167168C2 (en) 1970-08-20 1971-08-20 Liquid nutrient medium containing liver digestive broth, extract or infusion for the anaerobic cultivation of Fusiformis nodosus and a method for the anaerobic cultivation of Fusiformis nodosus
NO2548/72A NO141565C (en) 1970-08-20 1972-07-17 PROCEDURE FOR THE PREPARATION OF A VACCINE FOR CLOVE DISEASE
AR19595473D AR195954A1 (en) 1970-08-20 1973-01-01 METHOD FOR PREPARING A FUSIFORMIS NODOSUS VACCINE

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB4026070A GB1375544A (en) 1970-08-20 1970-08-20
GB3908371 1971-11-19

Publications (1)

Publication Number Publication Date
GB1375544A true GB1375544A (en) 1974-11-27

Family

ID=26264002

Family Applications (1)

Application Number Title Priority Date Filing Date
GB4026070A Expired GB1375544A (en) 1970-08-20 1970-08-20

Country Status (1)

Country Link
GB (1) GB1375544A (en)

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB2197193A (en) * 1986-11-05 1988-05-18 Oldcastle Veterinary Research Preparing vaccines
GB2546534A (en) * 2016-01-22 2017-07-26 Novabiotics Ltd Culture medium

Cited By (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB2197193A (en) * 1986-11-05 1988-05-18 Oldcastle Veterinary Research Preparing vaccines
GB2197193B (en) * 1986-11-05 1990-05-16 Oldcastle Veterinary Research A method of preparing an autogenous vaccine
GB2546534A (en) * 2016-01-22 2017-07-26 Novabiotics Ltd Culture medium

Similar Documents

Publication Publication Date Title
Gordon et al. STUDIES ON IMMUNITY TO TOXINS OF CLOSTRIDIUM BOTULINUM III: Preparation, Purification, and Detoxification of Type E Toxin
Nigg et al. Studies on the cultivation of the typhus fever rickettsia in the presence of live tissue
GB1375544A (en)
US2498165A (en) Process for producing bacitracin
GB1441098A (en) Biological preparations
Miller Jr et al. Studies on the stability of lyophilized BCG vaccine
Artenstein et al. Meningococcal infections: 3. Studies of group A polysaccharide vaccines
US4503036A (en) Process for producing a biochemical vaccine against Salmonella infection
GB1375866A (en)
US3035980A (en) Bacterial vaccines with p-hydroxybenzoates and their production
ES484187A1 (en) Combined vaccine active against Newcastle disease and egg production drop caused by adeno-like viruses, process for preparing it, adeno-like and Newcastle disease virus strains.
Converse et al. Experimental primary cutaneous coccidioidomycosis in the monkey
Smadel Intracellular infections
Woglom et al. The nature of a pyogenic filterable agent in the white rat
Cameron The significance of the endotoxin and pyogenic factor of Corynebacterium pseudotuberculosis in immunity
Artenstein Meningococcal infections: 4. Stability of group A and group C polysaccharide vaccines
Deacon et al. Study of Ducrey's bacillus and recognition of a gram-positive smooth phase.
Francis Twenty-year survival of virulent Bacillus pestis cultures without transfer
GB1436323A (en) Cell and virus culture systems
US4429046A (en) Large scale cultivation of Bordetella pertussis cells for vaccine production
Olitzki et al. Immunological studies on bovine leptospirosis
KR920006496A (en) Method for preparing oral typhoid vaccine
Menezes III-The a virulence of the cultivated y strain of trypanosoma cruzi
RU2190424C1 (en) Antigenic composition of plague chemical vaccine
Corper et al. The Primary Toxicity of Certain Preparations from Tubercle Bacilli for Mice and Guinea-Pigs

Legal Events

Date Code Title Description
PS Patent sealed
PCNP Patent ceased through non-payment of renewal fee